New podcast looks at the future of digital healthcare
Transforming Healthcare, the newest podcast series looking into the healthcare sector in the UK and globally, launches to international audiences on all major platforms later this month.
When was the last time you reviewed your employee benefits?
HR Dept's new blog discusses the principles behind having an employee benefits package and why you should review it periodically to ensure it is delivering value to you and your employees.
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions
Source of business for biosimilars in immunology
As of August 2023, there were 40 FDA-approved biosimilar products, including 25 commercially available products and four with interchangeable status.
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
Cambridge, UK: SolasCure, a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and which aims to accelerate wound debridement and contribute to wound bed preparation & healing, announces the results of its proof-of-concept, first-in-human, Phase IIa safety study.
Event filming and webcasting at Slido
WaveFX writes...We love Slido and were thrilled to manage their latest webcast streaming directly into their platform, (which was a first).
Guardtech Group feeling festive after racking up over 7,000sqm of construction crackers
Haverhill-based cleanroom design & build experts sleigh it at home and overseas after delivering a 2023 of great gifts for clients
DeepMirror launches early access programme for its intuitive molecular drug design software
Cambridge, UK - DeepMirror, a University of Cambridge spin-out company developing intuitive design software for the discovery of novel therapeutic drugs, announces the launch of its Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. The software allows users to tap into AI-driven insights to improve and…
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering with an automated solution for advanced discovOptibrium’s quantum mechanics and machine learning methods predict routes of drug metabolism
Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches.
Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism
Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches
Meet Cambridge brings Christmas cheer by supporting Toy Collection Initiative
The official conference and events bureau for Cambridge is marking the end of its 25th anniversary year by supporting a local Toy Drive to donate toys to children and young people who may otherwise not receive a gift this Christmas.
Guardtech appoint new Nordics & Baltics specialist to upscale cleanroom construction service in region
UK cleanroom design & build experts recruit Territory Manager Lars Strandljung to offer dedicated provision in Scandinavia and beyond
Dina van Well joins Salus Wellness this month
Salus Wellness says...we are very pleased to announce that Dina van Well has joined Salus Wellness this month.
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, announces it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in the year1, the appointment forms part of the Company’s growth plans to expand commercialisation of its pioneering DNA synthesis…
Evonetix announces agreement for revolutionary Gene Synthesis Platform with Analog Devices
Cambridge, UK, 06 December 2023 – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader. This agreement signals the continuation of the long-standing combined work of both companies,…
Meet Helena Ahlfors, our new Head of Research Data and Technology at the BioResource
Find out more about Helena, including why she chose to work at the BioResource, her hobbies, and the best book she's ever read!
Making AI work for you: 6 tips to future-proof your career
Career Ambitions writes...How do you feel about the rapid development in AI? Fascinated? Terrified? Maybe a little bit of both? Whilst the possibilities it offers are undoubtedly exciting, the alarming predictions in the media about how AI could kill certain jobs, has left many of us feeling anxious about how our future careers will look in an AI world.
International Day of Persons with Disabilities 2023 & reflection on our work with Purple Goat
In celebration of the International Day of Persons with Disabilities 2023 and Disability History Month, the BioResource would like to share some of the Diversity, Equity and Inclusion work we have been doing via our partnership with the inclusive marketing agency, Purple Goat.
Inward investment service attracts health tech pioneer to set up its global HQ in Cambridgeshire
An Australian-founded health tech company opened its global HQ in Cambridgeshire due to the support provided by the Combined Authority’s dedicated inward investment service branded as Locate Cambridge.
CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing
PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822 Submission represents first example of an OOC provider’s data supporting clinical progression of a drug for metabolic, fibrotic liver diseaseArecor signs co-development and exclusive licence option agreement with leading global medical products company for in-house speciality hospital product
Arecor-developed, Arestat™-enabled product is potentially first ready-to-dilute liquid formulation of a high-value oncology therapy
Double your donation with the Big Give
Tom’s Trust is joining forces with the Big Give again this year to double supporters’ donations and launch its Christmas campaign for 2023. The campaign, ‘Donate Your Last Hour’, encourages the charity’s supporters to donate their last hour of wages in 2023, which will
Arecor continues collaboration with Lilly
Development of an enhanced formulation of Lilly proprietary product using Arecor’s formulation technology platform Arestat™
Clinical considerations & payer perspectives
Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a fresh round of questions concerning pricing, access and reimbursement.